Cargando…
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885367/ https://www.ncbi.nlm.nih.gov/pubmed/33753045 http://dx.doi.org/10.1016/j.htct.2021.01.004 |
_version_ | 1784660400228270080 |
---|---|
author | Lima, Keli Vicari, Hugo Passos Carlos, Jorge Antonio Elias Godoy da Silva, Jean Carlos Lipreri Figueiredo-Pontes, Lorena Lobo de Rego, Eduardo Magalhães Machado-Neto, João Agostinho |
author_facet | Lima, Keli Vicari, Hugo Passos Carlos, Jorge Antonio Elias Godoy da Silva, Jean Carlos Lipreri Figueiredo-Pontes, Lorena Lobo de Rego, Eduardo Magalhães Machado-Neto, João Agostinho |
author_sort | Lima, Keli |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8885367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-88853672022-03-04 Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax Lima, Keli Vicari, Hugo Passos Carlos, Jorge Antonio Elias Godoy da Silva, Jean Carlos Lipreri Figueiredo-Pontes, Lorena Lobo de Rego, Eduardo Magalhães Machado-Neto, João Agostinho Hematol Transfus Cell Ther Letter to the Editor Sociedade Brasileira de Hematologia e Hemoterapia 2022 2021-03-13 /pmc/articles/PMC8885367/ /pubmed/33753045 http://dx.doi.org/10.1016/j.htct.2021.01.004 Text en © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Letter to the Editor Lima, Keli Vicari, Hugo Passos Carlos, Jorge Antonio Elias Godoy da Silva, Jean Carlos Lipreri Figueiredo-Pontes, Lorena Lobo de Rego, Eduardo Magalhães Machado-Neto, João Agostinho Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
title | Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
title_full | Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
title_fullStr | Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
title_full_unstemmed | Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
title_short | Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
title_sort | obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885367/ https://www.ncbi.nlm.nih.gov/pubmed/33753045 http://dx.doi.org/10.1016/j.htct.2021.01.004 |
work_keys_str_mv | AT limakeli obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax AT vicarihugopassos obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax AT carlosjorgeantonioeliasgodoy obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax AT dasilvajeancarloslipreri obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax AT figueiredoponteslorenalobode obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax AT regoeduardomagalhaes obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax AT machadonetojoaoagostinho obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax |